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Introduction
============

Cardiopulmonary arrest is considered to be an uncommon event in pediatric patients and requires timely and high-quality cardiopulmonary resuscitation (CPR) to improve outcomes \[[@REF1],[@REF2]\]. Physicians-in-training see far fewer code-blue events than their predecessors did, so they have limited confidence in resuscitation skills \[[@REF3]\]. Mock code simulation training with active participation and debriefing may be an effective educational tool to fill this gap in their experience \[[@REF4]\]. Due to limited exposure to this situation, health care providers need to maintain and develop their resuscitation skills by going through these critical situations to prepare them to deal confidently with a future event \[[@REF5],[@REF6]\]. Several studies have shown a reduction in pediatric CPR knowledge and skills within a short period of time after training if the skills are not maintained and practiced \[[@REF6]-[@REF8]\].

A mock code, which is defined as a simulation exercise with a mannequin/human patient simulator that has no respiratory effort and/or no carotid pulse, helps to encourage interprofessional teams to collaborate and improve their teamwork and fast response skills \[[@REF9],[@REF10]\]. These capabilities are crucial to reach the best outcome when performing CPR in a real environment, as well as in the mock code scenario where patient safety is not a concern and the exercise allows us to measure and assess the performance level. This exercise can fill knowledge and practice gaps and prepare practitioners for real situations \[[@REF11]-[@REF13]\].

Moreover, conducting good debriefing after the simulation sessions and sustaining the program over time are other important elements that help to ensure a successful program and achieve better patient outcomes \[[@REF6],[@REF8],[@REF14]-[@REF17]\].

There are various approaches to resuscitation training. In situ simulation training holds the training session in a realistic environment and offers the opportunity to identify issues with the existing code processes, such as equipment availability, location, and functionality \[[@REF12],[@REF18]-[@REF20]\]. Several studies support the use of resuscitation training programs that are multidisciplinary sessions based on the latest resuscitation guidelines. Furthermore, mock code training programs minimize performance differences and help to improve the response time from the onset of loss of pulse to the initiation of chest compressions, the time spent administering the first dose of epinephrine, and defibrillation time \[[@REF13],[@REF21]-[@REF25]\].

Despite the educational model used in the mock code training program, the goal is to optimize the survival rate. Many of these programs found a strong correlation between the survival rate and high numbers of mock codes \[[@REF12],[@REF26]-[@REF28]\]. Therefore, it is suggested that the mock code simulation program be added to pediatric advance life support (PALS) training in pediatric residency programs to promote confidence in responding to pediatric resuscitation \[[@REF7],[@REF8],[@REF15],[@REF16]\].

Few studies have assessed the impact of mock code simulations on pediatric patient survival. Overall, it appears that this kind of simulation-based training had a significant positive effect on performance in a cardiac arrest situation \[[@REF6],[@REF8],[@REF12],[@REF13],[@REF15]\].

Our study aimed to assess the impact of a mock code simulation program on the resuscitation practice of resuscitation team, and patient outcome for children with cardiopulmonary arrest events in a tertiary pediatric academic center.

Materials and methods
=====================

Simulation program design and participants

The mock code simulation program at King Abdullah Specialized Children Hospital, Riyadh, was established in 2015. This institution is the largest pediatric tertiary care medical center under the Ministry of National Guard - Health Affairs in Saudi Arabia. The hospital's inpatient bed capacity is about 225, with the 25-bed pediatric intensive care unit (PICU) and nine specialized inpatient pediatric wards in which code simulation sessions have been conducted.

Pediatric Simulation Training and Education Program (PediSTEP) is a multidisciplinary simulation program and offers different types of simulation programs such as high-fidelity and low-fidelity simulation, interprofessional simulation, and in situ mock code simulation.

This in situ mock code simulation is held two to three times per month, at random time and place. It is announced as real code, allowing us to offer the training opportunity for team members in their real settings and work environment. The pediatric cardiac arrest team is composed of a pediatric resident as a team leader, pediatric ward nurses as first responders, pediatric intensive care nurse, respiratory therapist, pharmacist, and pediatric ward charge nurse.

Multiple scenarios have been designed, including different types of common arrhythmias with structured debriefing sessions that focus on CPR and resuscitation skills. A low-fidelity mannequin is used for this purpose, while other instruments used, such as defibrillators, oxygen, medications, suction machines, and resuscitation carts, are from actual ward settings.

Design, setting, and populations

This was a cohort retrospective study conducted at King Abdullah Specialized Children Hospital at King Abdulaziz Medical City in Riyadh, Saudi Arabia.

This study had two phases: Phase 1 before the mock code simulation program began (pre-intervention), between 1 June 2015 and 31 May 2016, and Phase 2 after the mock code program began (post-intervention), between 1 January 2017 and 31 December 2018; a six-month implementation period was excluded.

Ethics approval for the study was sought from our local Institutional Review Board (IRB) at King Abdullah International Medical Research Center prior to data collection, and as this was an observational retrospective study and no identifiers were collected, the IRB considered the study exempt from the need for informed consent.

All records of pediatric cardiopulmonary arrest occurring in the study periods have been reviewed. All patients aged one month to 14 years with cardiopulmonary arrest events that occurred in PICU or in the ER were excluded, as the settings of these two areas are different.

Outcomes and measurements

The primary aim of this study is to evaluate the impact of the mock code simulation program on team performance by assessing the CPR initiation time and time to the first dose of epinephrine.

The secondary aims were to evaluate the adherence of the code team to the American Heart Association (AHA) guidelines and to determine the impact of the mock code simulation program on the survival rate of pediatric patients with cardiopulmonary arrest at hospital discharge. AHA adherence has been reviewed through CPR records and CPR Committee reports.

Statistical analysis

Categorical variables collected were sex, admission location of cardiopulmonary arrest, specialty of the most responsible physician, the days when the CPR occurred (i.e., weekdays or weekends), timing of CPR (working hours/on-call hours), admission diagnosis, and comorbidities. The results are summarized as frequencies and corresponding p-values. Continuous variables age, weight, height, length of stay in the ward, time taken for the team leader to arrive, time to initiate CPR, duration of CPR, time taken to administer epinephrine, epinephrine doses, PICU stay duration, and length of stay in ward were compared between the pre- and post-intervention phases by using the Wilcoxon rank-sum test. The results are summarized as the means, standard deviations, and corresponding p-values. Odds ratios (ORs) were calculated for patient outcomes between pre- and post-intervention phases. The results are reported as ORs and corresponding 95% confidence intervals. AHA guidelines were compared between the pre- and post-intervention phases by using Fisher's exact test. Significance was declared using a p-value less than 0.05. Analysis was carried out using SAS version 9.3 (SAS Institute Inc., Cary, NC).

Results
=======

The study sample was collected from the pre-mock code simulation phases. Between 1 June 2015 and 31 May 2016, 15 participants were excluded because they were not a real code or seizure. In the post-mock simulation program period (between 1 January 2017 and 31 December 2018) there were 23 participants, and four of them were excluded due to the same reasons. The pre- and post-intervention groups were similar overall (Table [1](#TAB1){ref-type="table"}).

###### Baseline characteristics of the pre- and post-intervention groups

CPA, cardiopulmonary arrest.

\*p-value is based on the Wilcoxon rank-sum test.

\*\*p-value is based on the Fisher exact test.

  ----------------------------------- ------------------------------- -------------------------------- -----------
  Characteristics                     Pre-intervention group (n=13)   Post-intervention group (n=19)   p-value
  Age (months) (mean±SD)              12.61±16.07                     39.80±41.50                      0.043
  Age (years) (mean±SD)               1.05±1.34                       3.32±3.46                        0.043
  Height                              64.73±22.17                     73.71±26.74                      0.459\*
  Weight                              6.27±4.46                       11.69±7.26                       0.012\*
  Gender, n (%)                                                                                         
  Male                                10 (76.92)                      10 (52.63)                       0.267\*\*
  Female                              3 (23.08)                       9 (47.37)                         
  Admission location of CPA, n (%)                                                                      
  General pediatric wards             8 (61.54)                       11 (57.89)                        
  High dependency unit                3 (23.08)                       7 (36.84)                        0.566\*\*
  Surgery wards                       2 (15.38)                       1 (5.26)                          
  Most responsible physician, n (%)                                                                     
  General pediatric                   9 (69.23)                       15 (78.95)                        
  Surgery                             3 (23.08)                       3 (15.79)                        0.830\*\*
  Other specialty                     1 (7.69)                        1 (5.26)                          
  CPA days, n (%)                                                                                       
  Weekdays                            9 (69.23)                       11 (57.89)                       0.712\*\*
  Weekends                            4 (30.77)                       8 (42.11)                         
  CPA timings, n (%)                                                                                    
  Working hours                       5 (38.46)                       7 (36.84)                        1.000\*\*
  On-call hours                       8 (61.54)                       12 (63.16)                        
  Admission diagnosis, n (%)                                                                            
  Respiratory                         8 (61.54)                       10 (52.63)                        
  Cardiac                             0                               3 (15.79)                         
  Sepsis                              0                               2 (10.53)                        0.485\*\*
  Gastrointestinal                    1 (7.69)                        1 (5.26)                          
  Oncologic                           1(7.69)                         0                                 
  Neurologic                          3 (23.08)                       3 (15.79)                         
  Others                                                                                                
  Comorbidities, n (%)                                                                                  
  Neurological (yes)                  6 (46.15)                       7 (3.84)                         0.720\*\*
  Cardiac (yes)                       7 (53.85)                       5 (26.32)                        0.150\*\*
  Pulmonary (yes)                     3 (23.08)                       5 (27.78)                        1.000\*\*
  Immunology (yes)                    3 (23.08)                       7 (36.84)                        0.467\*\*
  Gastroenterology (yes)              3 (23.08)                       2 (10.53)                        0.374\*\*
  Post-surgery (yes)                  1 (7.69)                        0                                0.406\*\*
  ----------------------------------- ------------------------------- -------------------------------- -----------

The results showed a significant decrease in CPR initiation time by 22 seconds (p=0.031); however, no significant changes were noticed in the length of stay either in the hospital or in the PICU (Table [2](#TAB2){ref-type="table"}).

###### Cardiopulmonary arrest-related characteristics for pre- and post-intervention periods

CPR, cardiopulmonary resuscitation.

p-values are based on the Wilcoxon rank-sum test.

  ---------------------------------------------------------------------- ------------------------------- -------------------------------- ---------
  Characteristics                                                        Pre-intervention group (n=13)   Post-intervention group (n=19)   p-value
  Length of stay in ward (days) (mean±SD)                                9.69±15.32                      13.32±22.90                      0.448
  Time taken for the team leader to arrive (minutes) (mean±SD)           2±0.82                          1.68±1.11                        0.334
  Time to initiate CPR (minutes) (mean±SD)                               1.38±0.51                       1.16±0.69                        0.031
  CPR duration (minutes) (mean±SD)                                       22.54±22.83                     10.0±14.50                       0.022
  Time taken to give the first dose of epinephrine (minutes) (mean±SD)   3.38±1.33                       2.21±2.12                        0.067
  Epinephrine doses (mean±SD)                                            5.23±5.73                       3.50±5.49                        0.378
  ---------------------------------------------------------------------- ------------------------------- -------------------------------- ---------

The results did not show a significant difference in the survival rate or mortality within 28 days of the cardiopulmonary arrest event between the pre- and post-intervention groups (Table [3](#TAB3){ref-type="table"}).

###### Patient outcome comparison between pre- and post-intervention groups

CPA, cardiopulmonary arrest.

p-values are based on the Fisher exact test.

  ---------------------------------------- ------------------------------- -------------------------------- ---------
  Variables                                Pre-intervention group (n=13)   Post-intervention group (n=19)   p-value
  Patient outcome, n (%)                                                                                     
  Dead                                     5 (38.46)                       4 (21.05)                        0.426
  Alive                                    8 (61.54)                       15 (78.95)                        
  Mortality within 28 days of CPA, n (%)                                                                     
  Yes                                      6 (50)                          6 (31.58)                        0.452
  No                                       6 (50)                          13 (68.42)                        
  ---------------------------------------- ------------------------------- -------------------------------- ---------

These patient outcome results were similar to the data analysis using odds ratios between the pre- and post-intervention groups, which revealed that it was 2.3 times more likely to have surviving cases in the post-intervention phase than in the pre-intervention phase. However, the 95% confidence interval includes 1, which indicates that the results are not significant (Table [4](#TAB4){ref-type="table"}).

###### Patient outcome odds ratios between pre- and post-intervention groups

PICU, pediatric intensive care unit; OR, odds ratio.

The reference groups are alive cases.

  ---------------------------------------- ------- --------------
  Variables                                OR      95% CI
  Patient outcome (dead vs. alive)         2.343   0.487-11.265
  PICU discharge status (dead vs. alive)   3.750   0.661-21.251
  ---------------------------------------- ------- --------------

Regarding the AHA adherence, it was observed that adherence was better in some elements, such as CPR initiation time (p=0.019) and electrical therapy for shockable rhythm (p=0.007), while the results for other elements did not significantly change between the pre- and post-intervention phases (Table [5](#TAB5){ref-type="table"}).

###### Adherence to AHA guidelines pre- and post-intervention

AHA, American Heart Association; BLS, basic life support; PTL, pediatric resident team leader; PEA, pulseless electrical activity; VT, ventrical tachycardia; VF, ventrical fibrillation; ASY, asystole.

  ----------------------------------------------------------------------------------------------- ------------------------------- -------------------------------- ---------------- ------------ ----------- ---------------- --------
  AHA guidelines                                                                                  Pre-intervention group (n=13)   Post-intervention group (n=19)   p-value                                                    
                                                                                                  Met                             Not met                          Not applicable   Met          Not met     Not applicable    
  BLS initiated in less than 1 min from arrest time                                               9 (69.23)                       4 (30.77)                        0                19 (100)     0           0                0.019
  Epinephrine administered within 5 min of arrest                                                 8 (61.54)                       4 (30.77)                        1 (7.69)         11 (57.89)   1 (5.26)    7 (36.84)        0.051
  PEA/ASY or shock delivered if VT/VF                                                             8 (61.54)                       5 (38.46)                        0                17 (89.47)   2 (10.53)   0                0.090
  Every 2 min pulse time documented                                                               13 (100)                        0                                0                19 (100)     0           0                \-
  Every 2 min identification of rhythm (after PTL arrival)                                        8 (61.54)                       5 (38.46)                        0                16 (84.21)   3 (15.79)   0                0.219
  Every 2 min pulse checked                                                                       0                               1 (7.69)                         12 (92.31)       0            0           19 (100)         0.406
  Every 2 min Joules selected in case of shockable rhythm                                         3 (23.08)                       9 (69.23)                        1 (7.69)         11 (57.89)   1 (5.26)    7 (36.84)        0.0007
  Epinephrine documented for non-shockable rhythm (PEA and ASY) according to AHA guidelines       0                               1 (7.69)                         12 (92.31)       0            0           19 (100)         0.406
  Epinephrine documented for shockable rhythm (VF and pulseless VT) according to AHA guidelines   0                               1 (7.69)                         12 (92.31)       0            0           19 (100)         0.406
  Amiodarone given with the correct dose according to AHA guidelines                              0                               1 (7.69)                         12 (92.31)       0            0           19 (100)         0.406
  Amiodarone given at the correct time according to AHA guidelines                                3 (23.08)                       6 (46.15)                        4 (30.77)        5 (26.32)    2 (10.53)   12 (63.16)       0.07
  ----------------------------------------------------------------------------------------------- ------------------------------- -------------------------------- ---------------- ------------ ----------- ---------------- --------

Discussion
==========

Overall, the results in this study showed a significant improvement in team performance represented by a decrease in CPR initiation time after the mock code simulation program, in both the CRP initiation time analysis and the AHA adherence analysis, as both revealed faster CPR initiation, which may reflect that cardiac arrest recognition improved after the mock code simulation program, and the first responders initiated chest compression earlier. Other studies reported the same results related to the CPR initiation time, which was part of the team dynamics improvement in some of them \[[@REF21],[@REF25],[@REF29]\]. In our study, we did not find significant changes in the survival rate after the mock code simulation program, but the small sample size, which is one of the major study limitations, may have affected the results and made these changes difficult to trace, while the results of other studies showed better outcomes after implementing mock code simulation programs \[[@REF30]\]. Other factors, such as comorbidities and the nature of the disease at admission, should also be considered and make drawing conclusion about the study outcomes more challenging, especially because cardiopulmonary arrest events are still considered rare events in pediatric patients.

Conclusions
===========

The mock code simulation program can enhance overall CPR performance by improving cardiac arrest recognition and CPR initiation time and increasing adherence to AHA guidelines. These results suggest advantages of the mock simulation program in terms of team performance, while its impact on survival rate is not clear in this small sample. Thus, future research with a larger study sample size might show a significant relation between the mock code simulation program and survival.
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